Insiders Updates
KYMR’s short interest surges to 7.58 million shares
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Kymera Therapeutics Inc’s recent filing unveils that its Director BAKER BROS. ADVISORS LP acquired Company’s shares for reported $28.84 million
Kymera Therapeutics Inc’s recent filing unveils that its Director Ridloff Elena unloaded Company’s shares for reported $0.23 million on Jun
Kymera Therapeutics Inc’s recent filing unveils that its Director Ridloff Elena unloaded Company’s shares for reported $0.23 million on Jun
Kymera Therapeutics Inc’s recently made public that its Director Esposito Pamela unloaded Company’s shares for reported $0.25 million on Jun